The two variants that modulates CSF SERPINE1 concentration, rs17705051 (VAT1L) and rs6092 (SERPINE1) failed to affect AD risk levels when assessed in our three distinct cohorts (Table 2). This evidence concerns the gene VAT1L and Alzheimer disease.